The chemokine SDF1/CXCL12: A novel autocrine/paracrine factor involved in pituitary adenoma development

Open Neuroendocrinology Journal

Volumn 4, Issue SPEC. ISSUE 1, 2011, Pages 64-76

  Barbieri, Federica ^a   Bajetto, Adriana ^a   Pattarozzi, Alessandra ^a   Gatti, Monica ^a   Würth, Roberto ^a   Porcile, Carola ^a   Thellung, Stefano ^a   Corsaro, Alessandro ^a   Villa, Valentina ^a   Nizzari, Mario ^a   Florio, Tullio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

CXCL12; CXCR4; CXCR7; Pituitary; Pituitary adenoma

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; BINDING SITE; CANCER GROWTH; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

EID: 80455149976     PISSN: None     EISSN: 18765289     Source Type: Journal    
DOI: 10.2174/1876528901104010064     Document Type: Article

References (138)

1. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 2001; 22: 147-184.
2. Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 2006; 7: 243.
3. Rostene W, Kitabgi P, Parsadaniantz SM. Chemokines: a new class of neuromodulator? Nat Rev Neurosci 2007; 8: 895-903.
4. Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett 2008; 267: 226-244.
5. Barbieri F, Bajetto A, Porcile C, Pattarozzi A, Schettini G, Florio T. Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. J Mol Endocrinol 2007; 38: 383-389.
6. Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007; 25: 787-820.
7. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000; 12: 121-127.
8. Rollins BJ. Chemokines Blood 1997; 90: 909-928.
9. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640-644.
10. Li M, Ransohoff RM. The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Semin Cancer Biol 2009; 19: 111-115.
11. Strieter RM, Belperio JA, Phillips RJ, Keane MP. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 2004; 14: 195-200.
12. Heesen M, Berman MA, Charest A, Housman D, Gerard C, Dorf ME. Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1. Immunogenetics 1998; 47: 364-370.
13. Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF- 1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005; 280: 35760-35766.
14. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213.
15. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009;113:6085-6093.
16. Mellado M, Rodriguez-Frade JM, Manes S, Martinez AC. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 2001; 19: 397-421.
17. Percherancier Y, Berchiche YA, Slight I, et al. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 2005; 280: 9895-9903.
18. Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, Albar JP, Martinez AC, Mellado M. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci U S A 1999; 96: 3628-3633.
19. O'Hayre M, Salanga CL, Handel TM, Allen SJ. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 2008; 409: 635-649.
20. Neptune ER, Bourne HR. Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. Proc Natl Acad Sci U S A 1997; 94: 14489-14494.
21. Neptune ER, Iiri T, Bourne HR. Galphai is not required for chemotaxis mediated by Gi-coupled receptors. J Biol Chem 1999; 274: 2824-2828.
22. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A 1994; 91: 2305-2309.
23. Shirozu M, Nakano T, Inazawa J, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995; 28: 495-500.
24. Doranz BJ, Orsini MJ, Turner JD, et al. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J Virol 1999; 73: 2752-2761.
25. Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I. Nterminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 1998; 273: 22279-22283.
26. De La Luz Sierra M,Yang F, Narazaki M, et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 2004; 103: 2452-2459.
27. Christopherson K, Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells 2001;19: 388-396.
28. Luster AD. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med. 1998; 338: 436-445.
29. Bajetto A, Bonavia R, Barbero S, Florio T, Costa A, Schettini G. Expression of chemokine receptors in the rat brain. Ann N Y Acad Sci 1999; 876: 201-209.
30. Ohtani Y, Minami M, Kawaguchi N, et al. Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci Lett 1998; 249: 163-166.
31. Stumm RK, Rummel J, Junker V, et al. A dual role for the SDF- 1/CXCR4 chemokine receptor system in adult brain: isoformselectiveregulation of SDF-1 expression modulates CXCR4- dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22: 5865-5878.
32. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635-638.
33. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595-599.
34. Bajetto A, Bonavia R, Barbero S, et al. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 1999; 73: 2348-2357.
35. Oh JW, Drabik K, Kutsch O, Choi C, Tousson A, Benveniste EN. CXC chemokine receptor 4 expression and function in human astroglioma cells. J Immunol. 2001; 166: 2695-2704.
36. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-877.
37. Barbero S, Bonavia R, Bajetto A, et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003; 63: 1969-1974.
38. Bajetto A, Barbero S, Bonavia R, et al. Stromal cell-derived factor- 1alpha induces astrocyte proliferation through the activation ofextracellular signal-regulated kinases 1/2 pathway. J Neurochem 2001; 77: 1226-1236.
39. Tilton B, Ho L, Oberlin E, et al. Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med 2000; 192: 313-124.
40. Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000; 86: 131-138.
41. Sasaki T, Irie-Sasaki J, Jones RG, et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000; 287: 1040-1046.
42. Roland J, Murphy BJ, Ahr B, et al. Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood 2003; 101: 399-406.
43. Cabioglu N, Summy J, Miller C, et al. CXCL-12/stromal cellderived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 2005; 65: 6493-6497.
44. Pattarozzi A, Gatti M, Barbieri F, et al. 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol Pharmacol 2008; 73: 191- 202.
45. Porcile C, Bajetto A, Barbieri F, et al. Stromal cell-derived factor- 1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 2005; 308: 241-253.
46. Rahimi M, George J, Tang C. EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and posttranslational mechanisms. Int J Cancer 2009.
47. Brand S, Dambacher J, Beigel F, et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 2005; 310: 117-130.
48. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno- Ortiz MC, Martinez AC, Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. Faseb J 1999; 13: 1699-1710.
49. Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE. Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 2001; 97: 3342-3348.
50. Moriguchi M, Hissong BD, Gadina M, et al. CXCL12 signaling is independent of Jak2 and Jak3. J Biol Chem 2005; 280: 17408-17414.
51. Chernock RD, Cherla RP, Ganju RK. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. Blood 2001; 97: 608-615.
52. Wain CM, Westwick J, Ward SG. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes. Cell Signal 2005; 17: 1194-1202.
53. Kim CH, Hangoc G, Cooper S, et al. Altered responsiveness to chemokines due to targeted disruption of SHIP. J Clin Invest. 1999; 104: 1751-1759.
54. Haraldsen G, Rot A. Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines. Eur J Immunol 2006; 36: 1659-1661.
55. Sierro F, Biben C, Martinez-Munoz L, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA. 2007; 104: 14759-14764. Epub 2007 Sep 5.
56. Thelen M, Thelen S. CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 2008; 198: 9-13. Epub 2008 Jun 3.
57. Hartmann TN, Grabovsky V, Pasvolsky R, et al. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokinetriggered motility of human T lymphocytes and CD34+ cells. J Leukoc Biol 2008; 84: 1130-1140.
58. Mahabaleshwar H, Boldajipour B, Raz E. Killing the messenger: The role of CXCR7 in regulating primordial germ cell migration. Cell Adh Migr 2008; 2: 69-70.
59. Wang J, Shiozawa Y, Wang Y, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283-4294.
60. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761-1767.
61. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007; 256: 137-165. Epub 2007 Jul 12.
62. Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE, Jiang WG. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 2005; 7: R402-R410.
63. Rempel SA, Dudas S, Ge S, Gutierrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000; 6: 102-111.
64. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
65. Sun YX, Wang J, Shelburne CE, et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003; 89: 462-473.
66. Robledo MM, Bartolome RA, Longo N, Rodriguez-Frade JM, Mellado M, Longo I, van Muijen GN, Sanchez-Mateos P, Teixido J. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001; 276: 45098-450105.
67. Kijima T, Maulik G, Ma PC, et al. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 2002; 62: 6304-6311.
68. Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277: 49481-4947.
69. Bertolini F, Dell'Agnola C, Mancuso P, et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 2002; 62: 3106-3112.
70. Thelen M, Stein JV. How chemokines invite leukocytes to dance. Nat Immunol 2008; 9: 953-959.
71. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004; 14: 171-179.
72. Bajetto A, Barbieri F, Dorcaratto A, et al. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 2006; 49: 423-432.
73. Rubin JB, Kung AL, Klein RS, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 2003; 100: 13513-13518.
74. Bajetto A, Barbieri F, Pattarozzi A, et al. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro-oncol 2007; 9: 3-11.
75. Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6: 459-469.
76. Lapteva N, Yang AG, Sanders DE, Strube RW, Chen SY. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther 2005; 12: 84-89.
77. Smith MC, Luker KE, Garbow JR, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004; 64: 8604-8612.
78. Luker KE, Luker GD. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 2006; 238: 30-41.
79. Hall JM, Korach KS. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 2003; 17: 792-803.
80. Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB. Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. Cancer Res 2005; 65: 11392-11399.
81. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 2001; 61: 4961-4965.
82. Wang J, Loberg R, Taichman RS. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 2006; 25: 573-587.
83. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. CCL21 chemokine regulates chemokine receptor CCR7bearing malignant melanoma cells. Clin Cancer Res 2004; 10: 2351-2358.
84. Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 2001; 93: 1638-1643.
85. Liotta LA. An attractive force in metastasis. Nature 2001; 410: 24-25.
86. Burger M, Glodek A, Hartmann T, Schmitt-Graff A, Silberstein LE, Fujii N, Kipps TJ, Burger JA. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 2003; 22: 8093-8101.
87. Arya M, Patel HR, McGurk C, et al. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. J Exp Ther Oncol 2004; 4: 291-303.
88. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 2006; 13: 191-199.
89. Geminder H, Sagi-Assif O, Goldberg L, et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001; 167: 4747-4757.
90. Scala S, Giuliano P, Ascierto PA, et al. Human melanoma metastases express functional CXCR4. Clin Cancer Res 2006; 12: 2427-2433.
91. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003; 63: 3833-3839.
92. Scotton CJ, Wilson JL, Scott K, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002; 62: 5930-5938.
93. Wang LH, Liu Q, Xu B, et al. Identification of nuclear localization sequence of CXCR4 in renal cell carcinoma by constructing expression plasmids of different deletants. Plasmid 2009.
94. Uchida D, Onoue T, Tomizuka Y, et al. Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol Cancer Res 2007; 5: 685-694.
95. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002; 62: 7203-7206.
96. Kato M, Kitayama J, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 2003; 5: R144-150.
97. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 2003; 167: 1676-1686.
98. Hassan S, Baccarelli A, Salvucci O, Basik M. Plasma stromal cellderived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 2008; 14: 446-454.
99. Mirisola V, Zuccarino A, Bachmeier BE, Sormani MP, Falter J, Nerlich A, Pfeffer U. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur J Cancer 2009; 45: 2579-2587.
100. Zhou W, Jiang Z, Song X, et al. Promoter hypermethylationmediated down-regulation of CXCL12 in human astrocytoma. J Neurosci Res 2008; 86: 3002-3010.
101. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 2006; 25: 4986-4997.
102. Wendt MK, Drury LJ, Vongsa RA, Dwinell MB. Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells. Gastroenterology 2008; 135: 508-517.
103. Haedo MR, Gerez J, Fuertes M, et al. Regulation of pituitary function by cytokines. Horm Res 2009; 72: 266-274.
104. Cunningham ET, Jr., Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci 1992; 12: 1101-1114.
105. Schettini G, Florio T, Meucci O, et al. Interleukin-1-beta modulation of prolactin secretion from rat anterior pituitary cells: involvement of adenylate cyclase activity and calcium mobilization. Endocrinology 1990; 126: 1435-1441.
106. Schettini G, Florio T, Meucci O, Scala G, Landolfi E, Grimaldi M. Effect of interleukin 1 beta on transducing mechanisms in 235-1 clonal pituitary cells. Part I: Modulation of adenylate cyclase activity. Biochem Biophys Res Commun 1988; 155: 1089-1096.
107. Schettini G, Meucci O, Florio T, Scala G, Landolfi E, Grimaldi M. Effect of interleukin 1 beta on transducing mechanisms in 235-1 clonal pituitary cells. Part II: Modulation of calcium fluxes. Biochem Biophys Res Commun 1988; 155: 1097-1104.
108. Koenig JI, Snow K, Clark BD, et al. Intrinsic pituitary interleukin-1 beta is induced by bacterial lipopolysaccharide. Endocrinology 1990; 126: 3053-3058.
109. Hanisch A, Dieterich KD, Dietzmann K, et al. Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas. J Clin Endocrinol Metab 2000; 85: 4411-4414.
110. Spangelo BL, Macleod RM. The role of immunopeptides in the regulation of anterior pituitary hormone release. Trends Endocrinol Metab 1990; 1: 408-412.
111. Renner U, Gloddek J, Arzt E, Inoue K, Stalla GK. Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mousepituitary tumor cells. Exp Clin Endocrinol Diabetes 1997; 105: 345-352.
112. Pereda MP, Lohrer P, Kovalovsky D, et al. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Exp Clin Endocrinol Diabetes 2000; 108: 202-207.
113. Spangelo BL, Judd AM, Isakson PC, MacLeod RM. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 1989; 125: 575-577.
114. Schettini G, Grimaldi M, Landolfi E, et al. Role of interleukin-6 in the neuro endocrine system. Acta Neurol (Napoli). 1991; 13: 361-367.
115. Grimaldi M, Meucci O, Scorziello A, et al. Interleukin 6 modulation of second messenger systems in anterior pituitary cells. Life Sci 1992; 51: 1243-1248.
116. Arzt E, Buric R, Stelzer G, et al. Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 1993; 132: 459-467.
117. Nagai Y, Watanabe K, Aso H, Ohwada S, Muneta Y, Yamaguchi T. Cellular localization of IL-18 and IL-18 receptor in pig anterior pituitary gland. Domest Anim Endocrinol 2006; 30: 144-154.
118. Sakamoto Y, Koike K, Kiyama H, et al. Endotoxin activates a chemokinergic neuronal pathway in the hypothalamo-pituitary system. Endocrinology 1996; 137: 4503-4506.
119. Sawada T, Koike K, Kanda Y, et al. In vitro effects of CINC/gro, a member of the interleukin-8 family, on hormone secretion by rat anterior pituitary cells. Biochem Biophys Res Commun 1994; 202: 155-160.
120. Tecimer T, Dlott J, Chuntharapai A, Martin AW, Peiper SC. Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells. Arch Pathol Lab Med 2000; 124: 520-525.
121. Koike K, Sakamoto Y, Sawada T, et al. The production of CINC/gro, a member of the interleukin-8 family, in rat anterior pituitary gland. Biochem Biophys Res Commun 1994; 202: 161-167.
122. Zhang ZX, Koike K, Sakamoto Y, et al. Pituitary folliculo-stellatelike cell line produces a cytokine-induced neutrophil chemoattractant. Neuropeptides 1997; 31: 46-51.
123. Licinio J, Wong ML, Gold PW. Neutrophil-activating peptide- 1/interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. Neuroreport 1992; 3: 753-756.
124. Banisadr G, Dicou E, Berbar T, Rostene W, Lombet A, Haour F. Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J Neuroimmunol 2000; 110: 151-160.
125. Banisadr G, Fontanges P, Haour F, Kitabgi P, Rostene W, Melik Parsadaniantz S. Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci 2002; 16: 1661-1671.
126. Florio T, Casagrande S, Diana F, et al. Chemokine stromal cellderived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals. Mol Pharmacol 2006; 69: 539-546.
127. Massa A, Casagrande S, Bajetto A, et al. SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2. Ann N Y Acad Sci 2006; 1090: 385-398.
128. Lee Y, Kim JM, Lee EJ. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation. J Endocrinol 2008; 199: 191-199.
129. Callewaere C, Banisadr G, Desarmenien MG, et al. The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc Natl Acad Sci USA 2006; 103: 8221-8226. Epub 2006.
130. Barbieri F, Bajetto A, Stumm R, et al. Over expression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res 2008; 14: 5022-5032.
131. Asa SL. Practical pituitary pathology: what does the pathologist need to know? Arch Pathol Lab Med 2008; 132: 1231-1240.
132. Green VL, Atkin SL, Speirs V, et al. Cytokine expression in human anterior pituitary adenomas. Clin Endocrinol (Oxf). 1996; 45: 179-185.
133. Suliman ME, Royds JA, Baxter L, Timperley WR, Cullen DR, Jones TH. IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas. Eur J Endocrinol 1999; 140: 155-158.
134. Lee YH, Noh TW, Lee MK, Larry Jameson J, Lee EJ. Absence of activating mutations of CXCR4 in pituitary tumours. Clin Endocrinol (Oxf) 2010; 72(2): 209-213.
135. Nomura R, Yoshida D, Teramoto A. Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia. J Neurooncol 2009; 94: 173-181.
136. Yoshida D, Nomura R, Teramoto A. Signaling Pathway Mediated by CXCR7, an Alternative Chemokine Receptor for Stromal-Cell Derived Factor-1alpha, in AtT20 mouse ACTH-secreting pituitary adenoma cells. J Neuroendocrinol 2009; 21: 481-488.
137. Florio T, Barbieri F, Spaziante R, et al. Efficacy of a dopaminesomatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. Endocr Relat Cancer 2008; 15: 583-596.
138. Yoshida D, Koketshu K, Nomura R, Teramoto A. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells. J Neurooncol 2010.